Human BMCC1 gene
    1.
    发明授权
    Human BMCC1 gene 有权
    人类BMCC1基因

    公开(公告)号:US07238796B2

    公开(公告)日:2007-07-03

    申请号:US10487593

    申请日:2002-08-23

    IPC分类号: C07H21/02

    CPC分类号: C07K14/47

    摘要: Human BMCC1 protein having an amino acid sequence set forth in SEQ ID NO:1 in the Sequence Listing and its variant protein, as well as human BMCC1 gene having a base sequence set forth in SEQ ID NO:2 in the Sequence Listing and its variant gene.

    摘要翻译: 具有序列表中SEQ ID NO:1所示的氨基酸序列及其变体蛋白质的人BMCC1蛋白质,以及具有序列表的序列号2所示的碱基序列的人BMCC1基因及其变体 基因。

    Genome DNA of bacterial symbiont of aphids
    4.
    发明授权
    Genome DNA of bacterial symbiont of aphids 失效
    蚜虫细菌共生体的基因组DNA

    公开(公告)号:US06632935B2

    公开(公告)日:2003-10-14

    申请号:US09790988

    申请日:2001-02-23

    IPC分类号: C07H2104

    CPC分类号: C07K14/195

    摘要: The present invention provides a genomic DNA of Buchnera. That is, this invention provides genes derived from Buchnera sp., comprising DNA of the following (a) or (b); (a) a DNA selected from a group consisting of a DNA having a nucleotide sequence ranging from a start point to an end point as shown in Table 1 in a nucleotide sequence represented by SEQ ID NO:1, or a DNA complementary thereto, and (b) a DNA hybridizing to the DNA of (a) under stringent conditions and encoding a protein having a function same as that of the product expressed by the DNA.

    摘要翻译: 本发明提供了Buchnera的基因组DNA。 也就是说,本发明提供了由Buchnera sp。衍生的基因,其包含以下(a)或(b)的DNA:(a)选自下组的DNA:(a) 起始点到如SEQ ID NO:1所示的核苷酸序列中的表1所示的终点或与其互补的DNA,和(b)在严格条件下与(a)的DNA杂交的DNA 并编码具有与由DNA表达的产物相同功能的蛋白质

    MIXTURE, DISSOLVING SOLUTION AND PHARMACEUTICAL AGENT EACH COMPRISING THERMOPHILIC MICROORGANISM
    5.
    发明申请
    MIXTURE, DISSOLVING SOLUTION AND PHARMACEUTICAL AGENT EACH COMPRISING THERMOPHILIC MICROORGANISM 审中-公开
    混合,溶解解决方案和药物代理每个包含热生物微生物

    公开(公告)号:US20120301450A1

    公开(公告)日:2012-11-29

    申请号:US13577314

    申请日:2011-02-09

    IPC分类号: A61K35/74 A61P37/04 A61P3/00

    CPC分类号: A61K35/741 C12R1/01 C12R1/07

    摘要: To provide a mixture, a dissolving solution and a pharmaceutical agent, which contain a thermophilic microorganism to make it possible to regulate a mucous membrane immune system gene cluster and metabolism-related gene clusters of the intestines and the liver. Each of them is prepared by fermentation of an organic material containing a thermophilic microorganism at a temperature of 50° C. or more and 90° C. or less. By being administered to the animal, it regulates at least one of a mucous membrane immune system gene cluster, a metabolism-related gene cluster in the intestines, and a metabolism-related gene cluster in the liver of the animal. The microorganism includes at least one species of the genus Bacillus, Oceanobacillus, Paenibacillus, Anoxybacillus, Lysinibacillus, Methanopyrus, Geogemma, Pyrolobus, Pyrodictium, Hyperthermus, Pyrococcus, Pyrobaculum, Thermococcus, Aeropyrum, Aquifex, Thermotoga, Thermodesulfobacterium, Thermus, Geobacillus, and Thermomyces.

    摘要翻译: 提供含有嗜热微生物的混合物,溶解溶液和药剂,以便调节粘膜免疫系统基因簇和代谢相关的肠和肝的基因簇。 它们各自通过在50℃以上且90℃以下的温度下发酵含有嗜热微生物的有机材料来制备。 通过施用于动物,其调节粘膜免疫系统基因簇,肠中代谢相关基因簇和动物肝脏中代谢相关基因簇中的至少一种。 微生物包括芽孢杆菌属,海洋芽孢杆菌属,芽孢杆菌属,厌氧杆菌属,嗜热芽孢杆菌属,甲烷us霉,地热质属,火焰菌属,火炬菌属,热原,热球菌属,火腿菌属,热球菌属,艾氏梭菌属,Aquifex菌,热酵母菌,热链球菌属,栖热菌属,土芽孢杆菌属和Thermomyces 。